These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 303135)

  • 1. Smoking and intermediate alpha1-antitrypsin deficiency and lung function in middle-aged men.
    Larsson C; Eriksson S; Dirksen H
    Br Med J; 1977 Oct; 2(6092):922-5. PubMed ID: 303135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung distensibility and airway function in intermediate alpha 1-antitrypsin deficiency (Pi MZ).
    Tattersall SF; Pereira RP; Hunter D; Blundell G; Pride NB
    Thorax; 1979 Oct; 34(5):637-46. PubMed ID: 316207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interrelationships between neutrophil elastase, serum alpha, -antitrypsin, lung function and chest radiography in patients with chronic airflow obstruction.
    Abboud RT; Rushton JM; Grzybowski S
    Am Rev Respir Dis; 1979 Jul; 120(1):31-40. PubMed ID: 313728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary function in heterozygotes for alpha,-antitrypsin deficiency: a case-control study.
    Buist AS; Sexton GJ; Azzam AM; Adams BE
    Am Rev Respir Dis; 1979 Oct; 120(4):759-66. PubMed ID: 315737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermediate alpha1-antitrypsin deficiency and chronic obstructive pulmonary disease in Yugoslavia.
    Kozarevic D; Laban M; Budimir M; Vojvodic N; Roberts A; Gordon T; McGee DL
    Am Rev Respir Dis; 1978 Jun; 117(6):1039-43. PubMed ID: 307352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung function studies in asymptomatic individuals with moderately (Pi SZ) and severely (Pi Z) reduced levels of alpha1-antitrypsin.
    Larsson C; Dirksen H; Sundström G; Eriksson S
    Scand J Respir Dis; 1976; 57(6):267-80. PubMed ID: 1087749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of smoking and intermediate alpha 1-antitrypsin deficiency (PiMZ) on lung function.
    Eriksson S; Lindell SE; Wiberg R
    Eur J Respir Dis; 1985 Oct; 67(4):279-85. PubMed ID: 3878302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevalence of alpha-antitrypsin heterozygotes (Pi MZ) in patients with obstructive pulmonary disease.
    Shigeoka JW; Hall WJ; Hyde RW; Schwartz RH; Mudholkar GS; Speers DM; Lin CC
    Am Rev Respir Dis; 1976 Dec; 114(6):1077-84. PubMed ID: 1087539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emphysema of early onset associated with a complete deficiency of alpha-1-antitrypsin (null homozygotes).
    Cox DW; Levison H
    Am Rev Respir Dis; 1988 Feb; 137(2):371-5. PubMed ID: 3257661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protease inhibitors in patients with chronic obstructive pulmonary disease: the alpha-antitrypsin heterozygote controversy.
    Cox DW; Hoeppner VH; Levison H
    Am Rev Respir Dis; 1976 May; 113(5):601-6. PubMed ID: 1083700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-1-antitrypsin deficiency in a Southland family.
    Browne RL
    N Z Med J; 1975 Nov; 82(551):291-3. PubMed ID: 1082114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural history and life expectancy in severe alpha1-antitrypsin deficiency, Pi Z.
    Larsson C
    Acta Med Scand; 1978; 204(5):345-51. PubMed ID: 309708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial.
    Chapman KR; Burdon JG; Piitulainen E; Sandhaus RA; Seersholm N; Stocks JM; Stoel BC; Huang L; Yao Z; Edelman JM; McElvaney NG;
    Lancet; 2015 Jul; 386(9991):360-8. PubMed ID: 26026936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic obstructive pulmonary disease and alpha-1-antitrypsin (Pi) variation: a family study.
    Benjamin JJ; Cohen BH; Ball WC; Levy DA; Menkes HA; Kreiss P
    Birth Defects Orig Artic Ser; 1974; 10(4):212-6. PubMed ID: 4549777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Collaborative study to assess risk of lung disease in Pi MZ phenotype subjects.
    Bruce RM; Cohen BH; Diamond EL; Fallat RJ; Knudson RJ; Lebowitz MD; Mittman C; Patterson CD; Tockman MS
    Am Rev Respir Dis; 1984 Sep; 130(3):386-90. PubMed ID: 6332562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bronchial reactivity, smoking, and alpha1-antitrypsin. A population-based study of middle-aged men.
    Kabiraj MU; Simonsson BG; Groth S; Björklund A; Bülow K; Lindell SE
    Am Rev Respir Dis; 1982 Nov; 126(5):864-9. PubMed ID: 6983320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterozygous alpha 1-antitrypsin deficiency: a longitudinal lung function study.
    de Hamel FA; Carrell RW
    N Z Med J; 1981 Dec; 94(697):407-10. PubMed ID: 6977750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pi-Z phenotypes in a pulmonary clinic. Their prevalence and physiologic state.
    Gerblich AA; Kleinerman J; Rynbrandt DJ; Chester EH; Ihrig J
    Am J Clin Pathol; 1978 May; 69(5):509-13. PubMed ID: 306745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of alpha-1-antitrypsin deficiency heterozygosity as a risk factor in the etiology of emphysema. Physiological comparison of adult normal and heterozygous protease inhibitor phenotype subjects from a random population.
    McDonagh DJ; Nathan SP; Knudson RJ; Lebowitz MD
    J Clin Invest; 1979 Feb; 63(2):299-309. PubMed ID: 311786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SPARTA clinical trial design: exploring the efficacy and safety of two dose regimens of alpha1-proteinase inhibitor augmentation therapy in alpha1-antitrypsin deficiency.
    Sorrells S; Camprubi S; Griffin R; Chen J; Ayguasanosa J
    Respir Med; 2015 Apr; 109(4):490-9. PubMed ID: 25727857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.